458 related articles for article (PubMed ID: 28296770)
1. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
Zheng S; He L; Yang X; Li X; Yang Z
Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
[TBL] [Abstract][Full Text] [Related]
5. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
6. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
7. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.
Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T
Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Initial Intrathecal Drug Ratio for Refractory Cancer-Related Pain for Early Pain Relief. A Retrospective Monocentric Study.
Dupoiron D; Leblanc D; Demelliez-Merceron S; Bore F; Seegers V; Dubois PY; Pechard M; Robard S; Delorme T; Jubier-Hamon S; Carvajal G; Lebrec N
Pain Med; 2019 Oct; 20(10):2033-2042. PubMed ID: 31329956
[TBL] [Abstract][Full Text] [Related]
11. Long-term intrathecal drug administration for chronic nonmalignant pain.
Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.
Liu HJ; Li WY; Chen HF; Cheng ZQ; Jin Y
Am J Hosp Palliat Care; 2017 Mar; 34(2):148-153. PubMed ID: 26537661
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison of intrathecal morphine to intravenous patient-controlled analgesia for the first 24 h post cesarean delivery: a retrospective cohort study.
Patel N; Bryant A; Duncan K; Kukreja P; Powell MF
J Anesth; 2017 Feb; 31(1):44-50. PubMed ID: 27743120
[TBL] [Abstract][Full Text] [Related]
15. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
Gestin Y; Vainio A; Pégurier AM
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
Nitescu P; Dahm P; Appelgren L; Curelaru I
Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
[TBL] [Abstract][Full Text] [Related]
18. Multimodal intrathecal analgesia in refractory cancer pain.
Mastenbroek TC; Kramp-Hendriks BJ; Kallewaard JW; Vonk JM
Scand J Pain; 2017 Jan; 14():39-43. PubMed ID: 28850428
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin enhances the antinociceptive effect of intrathecal morphine in refractory cancer pain patients.
Teng L; Dai J; Shao H; Zhao L; Lin S; Zhang W; Zou H
Support Care Cancer; 2021 Dec; 29(12):7611-7616. PubMed ID: 34131845
[TBL] [Abstract][Full Text] [Related]
20. More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain.
Mitchell A; Somerville L; Williams N; McGhie J; McConnachie A; McGinn G; Lee J
Palliat Med; 2023 Oct; 37(9):1461-1466. PubMed ID: 37632373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
